{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2026-01-09T12:26:10.717171+00:00",
  "news": [
    {
      "title": "AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPUUx5bW1JMG82U3I3c3JNMVFfNWVFcklFUUstVWNiQS0yWUdpLXBSTEE2TnlxRlRvOVhJUS1mUTdqeFEwZ3duNXZlV0dyWTNSVHhJeklDczI4aVpybkFVSXluaDA0b3g1WHdEZTJkNzVpbEw5XzNXbGlyRHd2QmV5NUNSTWVPdVVZdjZ0VUR1bHB2UkdLMDVKZkxwS3NWSkY4bUUwQlRWdG16UUFUcV8xWjdlWWhsQ2NZWXV0MjJrNA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxPUUx5bW1JMG82U3I3c3JNMVFfNWVFcklFUUstVWNiQS0yWUdpLXBSTEE2TnlxRlRvOVhJUS1mUTdqeFEwZ3duNXZlV0dyWTNSVHhJeklDczI4aVpybkFVSXluaDA0b3g1WHdEZTJkNzVpbEw5XzNXbGlyRHd2QmV5NUNSTWVPdVVZdjZ0VUR1bHB2UkdLMDVKZkxwS3NWSkY4bUUwQlRWdG16UUFUcV8xWjdlWWhsQ2NZWXV0MjJrNA?oc=5\" target=\"_blank\">AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2026-01-06T14:00:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "Amgen stitches new acquisition worth up to $840M for UK biotech and its cancer programs - Fierce Biotech",
      "link": "https://news.google.com/rss/articles/CBMirgFBVV95cUxORllWRVExTGxMODFRMHdDTjF3d093Y2RrM1NqNERDdkpHc2I4bXdDREowaFpxeWhYZERvcG5wdWtRMEl2YjZpWXZUV0VEWVRDQmhvR2x6eEt2ZklpLUl2eUpQN2VQZFUyNFVXSEJDeEU0Z3JlYUVHSVZoZUNhQXNhLWZVeUhSZFZBQzVZdEdycGtaeGdydVAwbmJjN1J3QjM3MUN4UUdCaXVYT0ZRWmc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMirgFBVV95cUxORllWRVExTGxMODFRMHdDTjF3d093Y2RrM1NqNERDdkpHc2I4bXdDREowaFpxeWhYZERvcG5wdWtRMEl2YjZpWXZUV0VEWVRDQmhvR2x6eEt2ZklpLUl2eUpQN2VQZFUyNFVXSEJDeEU0Z3JlYUVHSVZoZUNhQXNhLWZVeUhSZFZBQzVZdEdycGtaeGdydVAwbmJjN1J3QjM3MUN4UUdCaXVYT0ZRWmc?oc=5\" target=\"_blank\">Amgen stitches new acquisition worth up to $840M for UK biotech and its cancer programs</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Biotech</font>",
      "published": "2026-01-06T15:35:00+00:00",
      "source": "Fierce Biotech"
    },
    {
      "title": "Amgen buys protein-degrading startup Dark Blue for up to $840M - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQajF5MUNsd0IyX1V1RTlGZE10UDhCQWNRWkZOTXRlcHZMa1Z3ODdqNkRidW5RLURnWFl4QWpkbkI2RnllLV9uVEk5bTVWNUdjSE1hQWJkU0NyM2NlVDlmRkt5aE9hbGtHSE40MVFudzdTb2QtdjIwWW9pMDhPbVhKVjF1T2ZOcGw0RVgzT2lVTDY0RXdYNnFzWjdKRkJZdEg5eXc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiogFBVV95cUxQajF5MUNsd0IyX1V1RTlGZE10UDhCQWNRWkZOTXRlcHZMa1Z3ODdqNkRidW5RLURnWFl4QWpkbkI2RnllLV9uVEk5bTVWNUdjSE1hQWJkU0NyM2NlVDlmRkt5aE9hbGtHSE40MVFudzdTb2QtdjIwWW9pMDhPbVhKVjF1T2ZOcGw0RVgzT2lVTDY0RXdYNnFzWjdKRkJZdEg5eXc?oc=5\" target=\"_blank\">Amgen buys protein-degrading startup Dark Blue for up to $840M</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2026-01-06T16:48:14+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "Amgen swoops on UK cancer biotech in deal worth up to $840mn - Financial Times",
      "link": "https://news.google.com/rss/articles/CBMicEFVX3lxTE9oMzhkWTdYVlNSb0hOWjVaWHdFN05VOEUyMlJpQmdpTmdaaTJHR2ZMN0xCUXBFeERWNGd4cUwyUW5GWTVwQ0VuQ1o0NmdXdFVaeWxVWDdxN2c1aGtDNVEzVzRTUEwwclF1ZC1qZ0JnU2I?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMicEFVX3lxTE9oMzhkWTdYVlNSb0hOWjVaWHdFN05VOEUyMlJpQmdpTmdaaTJHR2ZMN0xCUXBFeERWNGd4cUwyUW5GWTVwQ0VuQ1o0NmdXdFVaeWxVWDdxN2c1aGtDNVEzVzRTUEwwclF1ZC1qZ0JnU2I?oc=5\" target=\"_blank\">Amgen swoops on UK cancer biotech in deal worth up to $840mn</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Financial Times</font>",
      "published": "2026-01-06T17:09:51+00:00",
      "source": "Financial Times"
    },
    {
      "title": "Amgen Makes up to $840M Cancer Play With Dark Blue Takeover - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQY3dFOThfeGJqTnJrdXh5ZnU4NEZNWnNIalQxVTdEUnF3LWV5a3lDMUl2ZjY5Y1dVQ3QxdjRNaVVkRGhFZGNfRWpjc0ZHbWZnT2R6MjRzb0ROdnlqY05sanRnSkdfV3Vjb1FTZ3RONnBIUVdFUTdmeWhSZzhNZWl0bTRxZk1MYVB6dmpYWFZ4MG9JQkhodkpv?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilwFBVV95cUxQY3dFOThfeGJqTnJrdXh5ZnU4NEZNWnNIalQxVTdEUnF3LWV5a3lDMUl2ZjY5Y1dVQ3QxdjRNaVVkRGhFZGNfRWpjc0ZHbWZnT2R6MjRzb0ROdnlqY05sanRnSkdfV3Vjb1FTZ3RONnBIUVdFUTdmeWhSZzhNZWl0bTRxZk1MYVB6dmpYWFZ4MG9JQkhodkpv?oc=5\" target=\"_blank\">Amgen Makes up to $840M Cancer Play With Dark Blue Takeover</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2026-01-07T13:06:32+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Amgen buys a novel leukaemia target | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline",
      "link": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOa044Y293MWYzbUxtYmNwNkpnM1NKQUJYcTVBZjBYb01vZnJRdDdiNXhvR1dkWDhmTERoMlFjVUYzUzgwbzBRcUtUTVhBbFp1dFJLRjFSQ3N3WW5RUllCYTY4aWlIb2NvODB2RHgwVkVlLV9zbWhXRU0xS3B1U2V5Ng?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMigAFBVV95cUxOa044Y293MWYzbUxtYmNwNkpnM1NKQUJYcTVBZjBYb01vZnJRdDdiNXhvR1dkWDhmTERoMlFjVUYzUzgwbzBRcUtUTVhBbFp1dFJLRjFSQ3N3WW5RUllCYTY4aWlIb2NvODB2RHgwVkVlLV9zbWhXRU0xS3B1U2V5Ng?oc=5\" target=\"_blank\">Amgen buys a novel leukaemia target | ApexOnco - Clinical Trials news and analysis</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Oncology Pipeline</font>",
      "published": "2026-01-06T17:30:50+00:00",
      "source": "Oncology Pipeline"
    },
    {
      "title": "Amgen to acquire Oxford spinout Dark Blue, tucking in a preclinical cancer drug - Endpoints News",
      "link": "https://news.google.com/rss/articles/CBMihAFBVV95cUxQZi10dWpNLTdLQWNQVEY4Zy04MmRET09KNzBlaXZ3RkUwNllPX0o2NFpEWEtZNGk4Y3FFT3VKaEFSblA5SklHSGNGbE5lZmV2MlJodU9oYnk5NVdNWGR5alBfWFZsMlpRd3ZXR0JPeElWMENnSnZkRDFwcUNXcjN3d2pyRTQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihAFBVV95cUxQZi10dWpNLTdLQWNQVEY4Zy04MmRET09KNzBlaXZ3RkUwNllPX0o2NFpEWEtZNGk4Y3FFT3VKaEFSblA5SklHSGNGbE5lZmV2MlJodU9oYnk5NVdNWGR5alBfWFZsMlpRd3ZXR0JPeElWMENnSnZkRDFwcUNXcjN3d2pyRTQ?oc=5\" target=\"_blank\">Amgen to acquire Oxford spinout Dark Blue, tucking in a preclinical cancer drug</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Endpoints News</font>",
      "published": "2026-01-06T15:49:00+00:00",
      "source": "Endpoints News"
    },
    {
      "title": "M&A News: Amgen Stock (AMGN) Brightens after $840M Capture of British Cancer-Fighting Biotech Dark Blue - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMixwFBVV95cUxNQkMzTWdVWGVhSjFfZnJTTUo0cmo3UXg0SGdjNnB3b0xBZmtjdUE0Z2lwMnBJcUZTWUFLMzExY2JfZm8tUW5uTUc5eDh4dlNwdC00YUtPd3JCOWJvUl9sY2VJUURmclZRYS1lUFRqbzBOOGVKU0pZLU1xb1M1RXRKNVdrTEM3dzdidHNNZnFveW52NTdYcUlrM1FNQ29aODdSbmo3QzRHeWFXV3dqTzJtZWJkRVZUQTRndkV4U2tZU0dUQzRnVm9V?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMixwFBVV95cUxNQkMzTWdVWGVhSjFfZnJTTUo0cmo3UXg0SGdjNnB3b0xBZmtjdUE0Z2lwMnBJcUZTWUFLMzExY2JfZm8tUW5uTUc5eDh4dlNwdC00YUtPd3JCOWJvUl9sY2VJUURmclZRYS1lUFRqbzBOOGVKU0pZLU1xb1M1RXRKNVdrTEM3dzdidHNNZnFveW52NTdYcUlrM1FNQ29aODdSbmo3QzRHeWFXV3dqTzJtZWJkRVZUQTRndkV4U2tZU0dUQzRnVm9V?oc=5\" target=\"_blank\">M&amp;A News: Amgen Stock (AMGN) Brightens after $840M Capture of British Cancer-Fighting Biotech Dark Blue</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2026-01-06T15:33:52+00:00",
      "source": "TipRanks"
    }
  ],
  "product_launches": [
    {
      "title": "A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-16T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach - simplywall.st",
      "link": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNLXhOdjVpSkxmUXdQRVpHS2tPVUdGcG1EZHJFZDZpNzg5Y3pCT3FTdlVhNFR4MmhicGVQN0luNnNVMkZCOTF5NkR0WWlUOXVtMmtfbzBJWVE4dUlwbjFXX29sREp3enhLVkowNV9QbXd4UGtMTlJjd29PSHNPSUd3TkhJNm55T1AxRTdUazNkd0NHRThWMGtTZU44V3lidnR5UmQyMWZxd0FrcHVPTVlfWTJWQTFMTGRQRDZQcEtaSlc0TklGNzlMam1pRjhDVVVpc0ZRStIB2gFBVV95cUxOV1VkLV9BSGdmbmR6anpGRENtdVctYTJEUUxEdXVCZ25PUV9qbHVNMGoyOFdxSE00TGk3QV9uV3Z2d1hTS0VJaEpmMXNJUzhIZTNjX2JnNHYwN29fQldveUsyWjhQQkR6bDh6dElyZlRDa0dnTDNxN0pNS0xUdVZwdGxaNmZpVVdDNFJ4U1RuZ040dy1wZUJkTXNKbzBIMkZzMlJ2U1c1TEloTmtFUGx3ZERfcGFQQURKUDNWcFdWVzJYQzM5dExHc2ZNQ2czcFU5c1pwOUxoV0NFQQ?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-09-08T07:00:00+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Strong first-quarter product sales for Amgen - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5\" target=\"_blank\">Strong first-quarter product sales for Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-05-02T07:00:00+00:00",
      "source": "The Pharma Letter"
    },
    {
      "title": "3 major patent losses this year — and a key strategy to fill the gaps - Pharma Voice",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5\" target=\"_blank\">3 major patent losses this year — and a key strategy to fill the gaps</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Pharma Voice</font>",
      "published": "2025-07-21T07:00:00+00:00",
      "source": "Pharma Voice"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2026-01-08",
      "close": 330.1099853515625
    },
    "history": [
      {
        "date": "2025-12-30",
        "close": 328.69000244140625
      },
      {
        "date": "2025-12-31",
        "close": 327.30999755859375
      },
      {
        "date": "2026-01-02",
        "close": 327.6400146484375
      },
      {
        "date": "2026-01-05",
        "close": 320.7200012207031
      },
      {
        "date": "2026-01-06",
        "close": 330.1700134277344
      },
      {
        "date": "2026-01-07",
        "close": 341.6400146484375
      },
      {
        "date": "2026-01-08",
        "close": 330.1099853515625
      }
    ],
    "name": "Amgen Inc."
  }
}